ArticleCancer biology & therapy2020

Cyclin E overexpression confers resistance to trastuzumab through noncanonical phosphorylation of SMAD3 in HER2+ breast cancer.

Joseph T Decker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.